How Early-Stage Biotech Companies Secure Non-Dilutive Funding
Join us for a practical and insightful conversation with Malachi Blundon, PhD, on navigating non-dilutive federal and private foundation funding in biotech and life sciences.
In this session, Malachi will share perspectives on how early-stage biotech companies can successfully access grant funding through federal institutes, such as the NSF and NIH, as well as private foundations. He will also share how Orange Grove Bio operates as an early-stage investor and venture builder, helping translate promising university innovations into scalable life science companies.
Malachi specializes in translating high-impact biotech innovations into fundable, scalable life science ventures. Having supported more than 40 biotech and life science startups, his experience spans therapeutics, diagnostics, and medtech, with expertise in grant strategy, startup operations, commercialization planning, and federal funding compliance. Attendees will gain a practical understanding of how startups can align scientific innovation with funding opportunities, navigate complex grant processes, and position themselves for long-term growth and commercialization success.
This session is designed for students, postdocs, researchers, founders, operators, and aspiring entrepreneurs interested in biotech innovation, translational science, and startup funding. Whether you are exploring how to fund early-stage research or looking to better understand the non-dilutive funding landscape, this conversation will provide actionable insights from someone working directly at the intersection of science, strategy, and startup execution.
Meet the Speaker
Malachi Blundon specializes in translating high-impact biotech innovations into fundable, scalable life science ventures. As Grant Administrator at Orange Grove Bio, he has played a key role in building and implementing non-dilutive fundraising strategies that have secured more than $8.86 million in funding from NIH and private foundations to support the development of therapies for cancer, autoimmune, and inflammatory diseases.
Meet the Host
Berkeley Pharma Tech Foundation is a nonprofit committed to expanding biotech understanding and improving access to the industry through education, mentorship, and networking. We host roundtables, speaker panels, and community events to connect aspiring scientists and entrepreneurs with industry leaders. Our goals: launch a funded research program within two years and build a state-of-the-art lab in the Bay Area within five. Follow us on LinkedIn or reach out to Vanloan Nguyen to get involved!